ICON Public Limited Company
ICLR
株式のランク
#1606
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
株価
$174.32
最終同期: 2026-10-20
時価総額
$13.45B
変化（1日）
3.68%
変化（1年）
-9.80%
国
IE
取引 ICON Public Limited Company (ICLR)
カテゴリー
Healthcare
ICON Public Limited Company（ICLR）の収益
Jun 2026 時点の収益 TTM: $8.25B
ICON Public Limited Company の最新の財務報告によると、現在の収益 (TTM) は $8.25B です。2023 年には $8.12B の収益があり、これは 2022 年の $7.74B と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
ICON Public Limited Company の収益履歴（2001 ～ 2026）
各年末の収益
| 年 | 収益 | 変化 |
|---|---|---|
| 2026 (TTM) | $8.25B | -0.35% |
| 2024 | $8.28B | 1.99% |
| 2023 | $8.12B | 4.89% |
| 2022 | $7.74B | 41.24% |
| 2021 | $5.48B | 95.93% |
| 2020 | $2.80B | -0.30% |
| 2019 | $2.81B | 8.09% |
| 2018 | $2.60B | 47.62% |
| 2017 | $1.76B | 5.52% |
| 2016 | $1.67B | 5.81% |
| 2015 | $1.57B | 4.77% |
| 2014 | $1.50B | 12.52% |
| 2013 | $1.34B | 19.83% |
| 2012 | $1.12B | 17.90% |
| 2011 | $945.73M | 5.08% |
| 2010 | $900.04M | 1.40% |
| 2009 | $887.61M | 2.58% |
| 2008 | $865.25M | 37.18% |
| 2007 | $630.72M | 38.44% |
| 2006 | $455.60M | 31.60% |
| 2005 | $346.20M | 16.60% |
| 2004 | $296.92M | 31.54% |
| 2003 | $225.73M | 44.18% |
| 2002 | $156.56M | 34.77% |
| 2001 | $116.16M | 0.00% |
同業他社の収益
| 企業 | 収益 | 収益の差 | 国 |
|---|---|---|---|
| $46.34B | 461.46% |
US
|
|
| $25.11B | 204.22% |
US
|
|
| $2.71B | -67.20% |
US
|
|
| - | - |
CN
|
|
| $7.37B | -10.67% |
US
|
